Corrigendum to “Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases”

Table 2

Summary of major findings for probiotic mediated cholesterol reduction.

Probiotic organism	Experimental system	Major findings [reference]
Unknown (fermented milk)	Maasai tribesmen in Africa	Low serum cholesterol [72]
Unknown (yogurt)	Human subjects	Reduced serum cholesterol [73]
L. acidophilus	Culture media	Cholesterol removal, better survival in cholesterol medium [31]
Bifidobacterium	Culture media	Removal of cholesterol [25]
L. acidophilus	Culture media	Cholesterol assimilation [74]
Probiotic-fermented milk	Rats	Cholesterol reducing efficacy [75]
L. reuteri	Mice	Reduced blood cholesterol, decreased triglycerides [76]
Bifidobacterium milk	Rats, human	Reduced cholesterol, decreased triglyceride, decreased LDL, increased HDL [77]
Yoghurt containing B. lactis or B. longum	Rats	Reduced cholesterol, decreased triglyceride, decreased LDL, increased HDL [78]
L. plantarum	Culture media	Cholesterol assimilation [17]
L. bulgaricus and L. acidophilus	Humans	Decreased cholesterol [107]
L. sporogenes	Humans	Decreased cholesterol, reduced LDL cholesterol [79]
L. acidophilus	Humans	Decreased cholesterol [108]
E. faecium	Humans	Decreased cholesterol, decreased triglyceride, decreased LDL, increased HDL [81]
Microencapsulated BSH-active L. reuteri NCIMB 30242	Humans	Decreased total cholesterol, reduced LDL cholesterol, decreased apoB-100, decreased non-HDL cholesterol [97]